Neurogene, a pioneering company dedicated to developing innovative genetic medicines for individuals suffering from debilitating neurological diseases, has successfully raised an impressive $200 million in its latest funding round. This substantial investment underscores the critical need for effective therapies targeting the underlying genetic causes of serious neurological disorders. With this new funding, Neurogene aims to significantly accelerate the advancement of its expansive pipeline of treatments designed to enhance the quality of life for children with neurologically-impaired conditions and their families. Despite the rapid progress made since the sequencing of the human genome nearly two decades ago, the true potential of genomics is only just beginning to unfold. Neurogene is at the forefront of this revolution, collaborating with experts worldwide to pioneer therapies that can reach even the rarest genetic disorders. The company is on a mission to ensure that every family, regardless of the uniqueness of their situation, has access to promising genetic medicines. Through this funding, Neurogene is poised to expand its team of dedicated professionals, all driven by a shared vision of transforming the landscape of genetic medicine. As they continue to break new ground in the field, the implications of this funding could lead to groundbreaking advancements that may one day allow all families to find hope and healing in genetic treatments. Interested individuals passionate about making a difference are encouraged to explore career opportunities with Neurogene at [www.neurogene.com/careers](http://www.neurogene.com/careers/).
Neurogene Secures $200 Million in Funding to Advance Genetic Medicines for Neurological Diseases
Recently funded 路 $200.0MHealthcare
Get the full Neurogene company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
